Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation.
Fang Y, Wang L, Wan C, Sun Y, Van der Jeught K, Zhou Z, Dong T, So KM, Yu T, Li Y, Eyvani H, Colter AB, Dong E, Cao S, Wang J, Schneider BP, Sandusky GE, Liu Y, Zhang C, Lu X, Zhang X. Fang Y, et al. Among authors: eyvani h. J Clin Invest. 2021 Jan 4;131(1):e140837. doi: 10.1172/JCI140837. J Clin Invest. 2021. PMID: 32990678 Free PMC article.
ST2 as checkpoint target for colorectal cancer immunotherapy.
Van der Jeught K, Sun Y, Fang Y, Zhou Z, Jiang H, Yu T, Yang J, Kamocka MM, So KM, Li Y, Eyvani H, Sandusky GE, Frieden M, Braun H, Beyaert R, He X, Zhang X, Zhang C, Paczesny S, Lu X. Van der Jeught K, et al. Among authors: eyvani h. JCI Insight. 2020 May 7;5(9):e136073. doi: 10.1172/jci.insight.136073. JCI Insight. 2020. PMID: 32376804 Free PMC article.
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity.
Zhou Z, Van der Jeught K, Fang Y, Yu T, Li Y, Ao Z, Liu S, Zhang L, Yang Y, Eyvani H, Cox ML, Wang X, He X, Ji G, Schneider BP, Guo F, Wan J, Zhang X, Lu X. Zhou Z, et al. Among authors: eyvani h. Nat Biomed Eng. 2021 Nov;5(11):1320-1335. doi: 10.1038/s41551-021-00805-x. Epub 2021 Nov 1. Nat Biomed Eng. 2021. PMID: 34725507 Free PMC article.
Metabolic interventions: A new insight into the cancer immunotherapy.
Yu T, Dong T, Eyvani H, Fang Y, Wang X, Zhang X, Lu X. Yu T, et al. Among authors: eyvani h. Arch Biochem Biophys. 2021 Jan 15;697:108659. doi: 10.1016/j.abb.2020.108659. Epub 2020 Nov 2. Arch Biochem Biophys. 2021. PMID: 33144083 Free PMC article. Review.
Demethylation and alterations in the expression level of the cell cycle-related genes as possible mechanisms in arsenic trioxide-induced cell cycle arrest in human breast cancer cells.
Moghaddaskho F, Eyvani H, Ghadami M, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Moghaddaskho F, et al. Among authors: eyvani h. Tumour Biol. 2017 Feb;39(2):1010428317692255. doi: 10.1177/1010428317692255. Tumour Biol. 2017. PMID: 28218039 Free article.
Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells.
Momeny M, Yousefi H, Eyvani H, Moghaddaskho F, Salehi A, Esmaeili F, Alishahi Z, Barghi F, Vaezijoze S, Shamsaiegahkani S, Zarrinrad G, Sankanian G, Sabourinejad Z, Hamzehlou S, Bashash D, Aboutorabi ES, Ghaffari P, Dehpour AR, Tavangar SM, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Momeny M, et al. Among authors: eyvani h. Int J Biochem Cell Biol. 2018 Jun;99:1-9. doi: 10.1016/j.biocel.2018.03.015. Epub 2018 Mar 19. Int J Biochem Cell Biol. 2018. PMID: 29567488
Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.
Momeny M, Sabourinejad Z, Zarrinrad G, Moghaddaskho F, Eyvani H, Yousefi H, Mirshahvaladi S, Poursani EM, Barghi F, Poursheikhani A, Dardaei L, Bashash D, Ghazi-Khansari M, Tavangar SM, Dehpour AR, Yaghmaie M, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Momeny M, et al. Among authors: eyvani h. Sci Rep. 2017 Apr 6;7:45954. doi: 10.1038/srep45954. Sci Rep. 2017. PMID: 28383032 Free PMC article.
Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells.
Momeny M, Zarrinrad G, Moghaddaskho F, Poursheikhani A, Sankanian G, Zaghal A, Mirshahvaladi S, Esmaeili F, Eyvani H, Barghi F, Sabourinejad Z, Alishahi Z, Yousefi H, Ghasemi R, Dardaei L, Bashash D, Chahardouli B, Dehpour AR, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Momeny M, et al. Among authors: eyvani h. Sci Rep. 2017 Jun 23;7(1):4204. doi: 10.1038/s41598-017-04147-0. Sci Rep. 2017. PMID: 28646172 Free PMC article.
14 results